NTRK1 and central nervous system cancer: The overexpression of the tyrosine kinase receptors (RTKs) and their ligands is among the most frequent alterations in glioma tumorigenesis, leading to alternate autocrine or paracrine stimulatory loops and to the aberrant activation of RTKs and their downstream molecular pathways.